Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: GlobeNewswire
TEL AVIV, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in March as follows: Barclays 27th Annual Global Healthcare ConferenceTuesday, March 11, 2025, at 8:00 am ETLeerink Partners Global Healthcare ConferenceWednesday, March 12, 2025, at 8:40 am ET To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations. An archived version of the webcast will be available within 24 hours after the end of the live discussion. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and T
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meetingGlobeNewswire
- Infertility Drugs Market to Reach USD 6.36 Billion by 2032 | Gonadotropins Segment Leads Growth, Online Pharmacies Emerging as Key Distribution Channel [Yahoo! Finance]Yahoo! Finance
- Here's Why Sound Shore Fund Added Teva Pharmaceutical Industries Limited (TEVA) in Q2 [Yahoo! Finance]Yahoo! Finance
- Teva's Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy [Yahoo! Finance]Yahoo! Finance
- Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System AtrophyGlobeNewswire
TEVA
Earnings
- 7/30/25 - Beat
TEVA
Analyst Actions
- 6/26/25 - UBS
TEVA
Sec Filings
- 9/12/25 - Form 144
- 9/9/25 - Form 4
- 8/6/25 - Form SCHEDULE
- TEVA's page on the SEC website